| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/29/2003 | EP1278823A2 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/29/2003 | EP0912188B1 Selective adsorbent for binding retroviruses |
| 01/29/2003 | EP0841942B1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 01/29/2003 | EP0703980B1 Intracellular binding proteins and use thereof |
| 01/28/2003 | US6511847 Recombinant adenovirus using liposome-mediated cotransfection and the direct observation of a cytopathic effect in the transfected cells; tumor suppressor gene |
| 01/28/2003 | US6511801 HIV-1 group O strain gp160 env precursor protein comprising the amino acid sequence of SEQ ID NO:100 |
| 01/28/2003 | US6511667 Attenuated dengue-2 virus vaccine |
| 01/23/2003 | WO2003006662A1 Anti-neoplastic viral agents |
| 01/23/2003 | WO2003006640A1 A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 01/23/2003 | WO2003005964A2 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002018585A3 Packaging of positive-strand rna virus replicon particles |
| 01/23/2003 | US20030018005 Autoimmune disease; antiinflammatory agents; antiallergens; rheumatic diseases; antitumor agents |
| 01/23/2003 | US20030017595 Cells for use as transformation and vector propagation tools in genetic engineering |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017450 Detection of viral nucleotide sequences in sample; obtain sample, denature, incubate with pimers, hybridize, amplify, expose to probe, detect signal presence indicates viral nucleotide sequences |
| 01/23/2003 | US20030017173 Arrestable therapeutic viral agent |
| 01/23/2003 | US20030017140 Retroviral vector particles have a chimeric envelope protein consisting of an antigen binding site of an antibody or another peptide, fused to the envelope protein the retroviral vector. |
| 01/23/2003 | US20030017138 Chimeric adenoviruses |
| 01/23/2003 | CA2453357A1 Anti-neoplastic viral agents |
| 01/23/2003 | CA2452517A1 Recombinant vsv for the treatment of tumor cells |
| 01/22/2003 | EP1276862A2 Heparanase ii, a human heparanase paralog |
| 01/22/2003 | EP1276853A1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 01/22/2003 | EP1276852A2 Viruses comprising mutated ion channel protein |
| 01/22/2003 | EP0853660B1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 01/22/2003 | CN1392255A Preparing method for preservative agent for chicken newcastle disease virus |
| 01/22/2003 | CN1392254A Recombined adenovirus and its use in curing myocardial ischemia |
| 01/22/2003 | CN1099460C Chicken merek's disease virus genic mutant strain and its use |
| 01/21/2003 | US6509514 Chimeric animal model susceptible to human hepatitis C virus infection |
| 01/21/2003 | US6509454 Free solution ligand interaction molecular separation method |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509150 Producing rAAV with very high yields of infectious particles and essentially free of detectable adenovirus contamination |
| 01/21/2003 | US6509146 Scalable long-term shelf preservation of sensitive biological solutions and suspensions |
| 01/21/2003 | US6509033 Immunomodulatory peptides |
| 01/21/2003 | US6509020 Replication-competent herpes simplex virus |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | CA2187624C Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
| 01/17/2003 | CA2352439A1 Engineering oncolytic viruses |
| 01/16/2003 | WO2003004661A2 Adenovital vectors with cell type specificity for mesenchymal cells |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2002053712A3 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 01/16/2003 | WO2002038104A3 Compositions and methods for reducing the amount of salmonella in livestock |
| 01/16/2003 | WO2002022080A8 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 01/16/2003 | WO2002018609A3 Methods for stable transduction of cells with viral vectors |
| 01/16/2003 | WO2001092549A3 Method and composition for targeting an adenoviral vector |
| 01/16/2003 | WO2001081375A9 Dna & protein binding miniature proteins |
| 01/16/2003 | WO2001059093A9 Full-length infectious cdna clones of tick borne flavivirus |
| 01/16/2003 | US20030013197 Generation of adenovirus associated vector cultures; obtain cells, infect with expression vector, express vector and recover viral particles |
| 01/16/2003 | US20030013195 Virus envelope vector for gene transfer |
| 01/16/2003 | US20030013190 Altered strain of the modified vaccinia virus ankara (mva) |
| 01/16/2003 | US20030013189 Noninvasive transfer of pharmocological agent into bloodstream; administer adenovirus to human, monitor response to pharmacological agent in lungs |
| 01/16/2003 | US20030013085 Production of replicative hepatitis C virus |
| 01/16/2003 | US20030013079 Generation of preferential viral particle; obtain cells, transform with expresion vector, culture cell, recover viral particle |
| 01/16/2003 | US20030013078 Expression vector for use in the prevention and treatment of vial infection |
| 01/16/2003 | US20030012770 Recombinant p53 adenovirus methods and compositions |
| 01/16/2003 | US20030012769 Wherein a part or all of a regulatory element of the U3 region of the 5' LTR is replaced by another regulatory element, operable in a mammalian cell, which is not endogenous to said lentivirus. |
| 01/16/2003 | CA2453100A1 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/15/2003 | EP1275716A2 Modified DNA molecule, recombinant containing the same thing, and uses thereof |
| 01/14/2003 | US6506604 Retroviral packaging system |
| 01/14/2003 | US6506557 Methods and compositions for identifying a protease |
| 01/09/2003 | WO2003002746A2 Perv screening method and use thereof |
| 01/09/2003 | WO2002092825A3 Retroviral vectors for gene therapy |
| 01/09/2003 | WO2002038774A3 Bacterial phytases and method for producing same |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002020041A3 Eia vaccine and diagnostic |
| 01/09/2003 | WO2002013855A3 Vaccines containing ribavirin and methods of use thereof |
| 01/09/2003 | WO2002002605A3 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/09/2003 | WO2001053504A9 Replication deficient adenovirus vectors |
| 01/09/2003 | US20030008836 Eukaryotic gene expression cassette and uses thereof |
| 01/09/2003 | US20030008399 Controlling viral replication or gene expression in a cell; obtain cell infected with virus, transform with nucleotide sequence expressng preferential replicases, monitor viral gene expression |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008390 Genetically engineered cell for use in the generation of viral vector for use in gene therapy |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008375 Generation of preferential adenoviral expression vector; obtain cells, infect with virus, harvest and lyse cell, recover vectors |
| 01/09/2003 | US20030008374 Methods and compositions relating to improved lentiviral vectors and their applications |
| 01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/09/2003 | US20030008330 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cancer and autoimmune disease |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008275 Attenuated HIV strains and use thereof |
| 01/09/2003 | US20030007979 Intranasal administering |
| 01/08/2003 | EP1272676A2 Hiv detection assay and reagents therefor |
| 01/08/2003 | EP1272652A2 Herpes viruses for immune modulation |
| 01/08/2003 | EP1272615A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/08/2003 | CN1389268A Hepatitis B DNA vaccine |
| 01/07/2003 | US6503753 Method for the development of an HIV vaccine |
| 01/07/2003 | US6503752 Lymphotropic agents and vectors |
| 01/07/2003 | US6503498 Apolipoprotein A-1 adenovirus vector compositions and methods |
| 01/03/2003 | WO2003001210A2 Retrovirus associated with myelodysplastic syndromes |
| 01/03/2003 | WO2003000888A2 Method for separating bacterial cells and cell components |
| 01/03/2003 | WO2003000872A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000855A2 Chimeric capsid proteins and uses thereof |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002044322A3 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 01/03/2003 | WO2002043647A3 Oncolytic virus |